Disparities in Cancer Survival Rates Among Patients of the Veterans Health Administration
Overview
This comprehensive review investigates cancer survival rates among veterans within the Veterans Health Administration (VHA), focusing on racial disparities.
Background
Despite advancements in cancer care leading to reduced mortality rates, significant disparities persist, particularly among Black populations in the general U.S. population. The VHA, serving over 9 million veterans, aims to provide equitable cancer care regardless of race.
Data Highlights
No numerical data or trial data was provided in the source material.
Key Findings
Black populations generally have lower cancer survival rates compared to White populations, even after adjusting for various factors.
Social determinants of health, such as socioeconomic status and access to healthcare, contribute to survival disparities.
The VHA provides standardized care, which may lead to comparable survival outcomes across racial groups.
A systematic review was conducted to evaluate overall survival (OS) and cancer-specific survival (CSS) by race among veterans treated in the VHA.
Meta-analysis was used to estimate pooled hazard ratios for OS and CSS across eligible studies.
Clinical Implications
Continued monitoring and evaluation of survival outcomes by race within the VHA are essential for ensuring equitable care.
Conclusion
This review highlights the importance of understanding cancer survival rates among veterans.
by Alyssa Jasmine Bullard, Haley I. Tupper, Kevin Su, Lin Gu, Luca F. Valle, Isla P. Garraway, Donna L. Washington, Chloe E. Bird, Robert A. Winn, Stephen J. Freedland, Christina D. Williams, Drew Moghanaki
